CClinicalTrials.gg
Enrolling by invitationNCT06758193Updated Apr 22, 2026

Validity and Reliability of the MAP-Hand Scale in Patients With Carpal Tunnel Syndrome

An observational study in Carpal Tunnel Syndrome (CTS), sponsored by Kirsehir Ahi Evran Universitesi. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Kirsehir Ahi Evran Universitesi · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
180
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The primary aim of the study was to determine the validity and reliability of the "MAP-Hand (Measure of Activity Performance of the Hand)" scale in patients with carpal tunnel syndrome. The secondary aim of the study was to evaluate the hand activity performance in patients with carpal tunnel syndrome.

02

Conditions studied

  • Carpal Tunnel Syndrome (CTS)

Keywords

  • Carpal Tunnel Syndrome
  • Reliability
  • Validity
03

In context

Carpal Tunnel Syndrome

589 studies on the registry are indexed under Carpal Tunnel Syndrome; 139 are open to participants now.

This study's planned enrollment of 180 is above the median of 90 across 127 observational studies indexed under Carpal Tunnel Syndrome.

Browse Carpal Tunnel Syndrome studies →

Lead sponsor

Kirsehir Ahi Evran Universitesi is the lead sponsor of 133 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients who apply to the Physical Medicine and Rehabilitation Polyclinic with complaints of hand-wrist pain will be examined by a physical therapist. Patients who are diagnosed with Carpal Tunnel Syndrome through physical examination, meet the inclusion criteria, and agree to participate in the study will be included in the study.

Inclusion criteria

  1. Age 18 and above and able to read and write
  2. Diagnosed with mild or moderate unilateral CTS according to electroneuromyography results at least 6 months ago
  3. Motor-sensory symptoms such as numbness and loss of strength in the hand for at least three months
  4. Volunteers with no history of diabetes, no medical treatment or injections, no surgery, and no cervical radiculopathy or polyneuropathy

Exclusion criteria

Exclusion Criteria:

  1. Those with trauma, deformity, fracture, muscle contracture and atrophy in the shoulder, forearm and hand
  2. Those who have received corticosteroid injections into the carpal tunnel area within the last three months and have been included in a physiotherapy program
  3. Those who have cognitive problems
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
180 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study Group

    Other: No intervention was applied in this study.

Interventions

  • OtherNo intervention was applied in this study.

    No intervention was applied in this study.

06

What researchers measure

Primary outcomes

  1. Hand Activity Performance

    The MAP-Hand (Measure of Activity Performance of the Hand) scale is a scale consisting of 18 items that evaluates the activity performance of the hand. These items are scored between 1 and 4 and the total score ranges from 18 to 72. Lower scores indicate better activity performance. The participants' hand activity performance will be evaluated with the MAP-Hand scale. The reliability and validity of the Turkish form of the MAP-Hand scale was conducted by Bayraktar and colleagues. However, their work has not yet been published. The necessary permissions have been obtained to use the scale.

    Time frame: 24 weeks

Secondary outcomes

  1. Grip Strength

    Hand grip strength will be measured with a Camry brand digital dynamometer. Participants will be assessed in an upright position on a chair with their feet on the floor, with their arm next to their body, elbow in 90-degree flexion, forearm in midrotation and wrist in neutral. Participants were verbally encouraged during the test. Measurements were repeated three times and the highest value will be recorded in kilograms.

    Time frame: 24 weeks

  2. Pain measurement

    The participants' pain intensity during rest, activity and night will be measured with VAS. According to VAS, pain intensity is evaluated on a 10 cm line between 0 (no pain) and 10 (most severe pain). High scores indicate severe pain. Participants will be asked to indicate the intensity of pain they feel on a 10 cm scale.

    Time frame: 24 weeks

  3. Hand and Finger Skills

    The participants' hand and finger skills will be tested with the 9-Hole Peg Test (9-DÇT). The 9-DÇT is a test that measures hand and finger skills in daily life. A pegboard with 9 holes, 3.2 cm wide, each hole 1.3 cm deep, will be placed in front of the participants in a way that it will be in the midline of the body. Participants will be asked to randomly place 9 wooden pins on the 9-hole pegboard as quickly as possible and then remove the pins from the pegboard one by one and put them in the box. At the end of 3 trials, the times will be recorded in seconds with a stopwatch and the shortest time will be recorded. A longer time to complete the test indicates inadequacy in hand-finger skills.

    Time frame: 24 weeks

  4. Hand Health Status

    Hand health status will be assessed with the "Michigan Hand Outcome Questionnaire (MESA)". MESA consists of 37 questions and is a questionnaire with 6 parameters that evaluate general hand function, daily living activities, pain, work, aesthetics and satisfaction. Each question is evaluated with a 5-point Likert scale and a high score indicates a good status.

    Time frame: 24 weeks

  5. Carpal Tunnel Symptom Severity

    The symptom severity and functional status of the participants will be evaluated with the "Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)". BCTQ consists of the symptom severity scale (SSS) and the functional status scale (FSS) that evaluate the patient in two categories. While the SSS consists of 11 items, the FSS consists of 8 items. The average score is calculated by the ratio of the total score obtained to the number of questions. An increase in the average score indicates that the symptom is severe and functional limitation increases.

    Time frame: 24 weeks

07

Study locations

1 site
  • Kirsehir Ahi Evran University
    Kırşehir, Merkez 40100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06758193
Lead sponsor
Kirsehir Ahi Evran Universitesi
Responsible party
Atahan TURHAN (Lecturer Dr., Kirsehir Ahi Evran Universitesi) — Principal investigator
First posted
Jan 3, 2025
Start date
Dec 10, 2024
Primary completion
May 1, 2026 (estimated)
Completion
Aug 1, 2026 (estimated)
Last update
Apr 22, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion